Abiopharma

21shares Announces Distributions on TETH, TSOL, THYP, TSUI and TDOT

Western Metallica Announces AGM Results

Viridian Therapeutics, Inc. - Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease

Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease

GameStop Provides Fiscal Year 2026 Outlook

Incyte gibt positive Stellungnahme des CHMP zu Opzelura ® (Ruxolitinib)-Creme zur Behandlung von Erwachsenen mit mittelschwerer atopischer Dermatitis bekannt

Incyte anuncia un dictamen favorable del CHMP sobre la crema Opzelura® (ruxolitinib) para tratar a los pacientes adultos con dermatitis atópica moderada

Incyte annuncia lopinione positiva del CHMP per Opzelura® (ruxolitinib) crema per il trattamento della dermatite atopica moderata in pazienti adulti

Incyte kondigt positief CHMP-advies aan voor Opzelura® (ruxolitinib)-crème voor de behandeling van volwassenen met matige atopische dermatitis

KBRA Comments on Colony Bancorp, Inc.s Proposed Merger with First Reliance Bancshares, Inc.